Assessing the utility of an institutional publications officer: A pilot assessment

PeerJ

Volumn 2017, Issue 5, 2017, Pages

  Cobey, Kelly D ^a,b,c   Galipeau, James ^a   Shamseer, Larissa ^a,b   Moher, David ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Manuscript reporting; Publication ethics; Publications officer; Scholarly publishing; Transparency

Indexed keywords

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SCIENTIST;

EID: 85019730672     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.3294     Document Type: Article

References (29)

1. Al-Shahi Salman R, Beller E, Kagan J, Hemminki E, Phillips RS, Savulescu J, Macleod M, Wisely J, Chalmers I. 2014. Increasing value and reducing waste in biomedical research regulation and management. The Lancet 383(9912):176-185 DOI 10.1016/S0140-6736(13)62297-7.
2. Altman DG. 1994. The scandal of poor medical research. BMJ 308:283-284 DOI 10.1136/bmj.308.6924.283.
3. Baker M. 2016. Is there a reproducibility crisis? Nature 533:452-454 DOI 10.1038/533452a.
4. Begley CG, Buchan AM, Dirnagl U. 2015. Robust research: institutions must do their part for reproducibility. Nature 525(7567):25-27 DOI 10.1038/525025a.
5. Begley CG, Ellis LM. 2012. Drug development: raise standards for preclinical cancer research. Nature 483(7391):531-533 DOI 10.1038/483531a.
6. Begley CG, Ioannidis JPA. 2015. Reproducibility in science: improving the standard for basic and preclinical research. Circulation Research 116(1):116-126 DOI 10.1161/CIRCRESAHA.114.303819.
7. Boutron I, Dutton S, Ravaud P, Altman DG. 2010. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results. Journal of the American Medical Association 303(20):2058-2064 DOI 10.1001/jama.2010.651.
8. Buck S. 2015. Solving reproducibility. Science 348(6242):1403 DOI 10.1126/science.aac8041 .
9. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, Howells DW, Ioannidis JP, Oliver S. 2014. How to increase value and reduce waste when research priorities are set. The Lancet 383(9912):156-165 DOI 10.1016/S0140-6736(13)62229-1.
10. Chan A, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG. 2004. Empirical evidence for selective reporting of outcomes in randomized trials. Journal of the American Medical Association 291(20):2457-2465 DOI 10.1001/jama.291.20.2457.
11. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gøtzsche PC, Krumholz HM, Ghersi D, Van Der Worp HB. 2014. Increasing value and reducing waste: addressing inaccessible research. The Lancet 383(9913):257-266 DOI 10.1016/S0140-6736(13)62296-5.
12. Cobey KD, Galipeau J, Shamseer L, Moher D. 2016. Report on a pilot project to introduce a publications officer. Canadian Medical Association Journal 188(12):E279-E280.
13. Collins FS, Tabak LA. 2012. NIH plans to enhance reproducibility. Nature 505(7485):612-613 DOI 10.1038/505612a.
14. Dwan K, Gamble C, Williamson PR, Kirkham JJ. 2013. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - An updated review. PLOS ONE 8(7):e66844 DOI 10.1371/journal.pone.0066844.
15. Freedman LP, Cockburn IM, Simcoe TS. 2015. The economics of reproducibility in pre- clinical research. PLOS Biology 13(6):e1002165 DOI 10.1371/journal.pbio.1002165.
16. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, Michie S, Moher D, Wager E. 2014. Reducing waste from incomplete or unusable reports of biomedical research. The Lancet 383(9913):267-276 DOI 10.1016/S0140-6736(13)62228-X.
17. Glasziou P, Meats E, Heneghan C, Shepperd S. 2008. What is missing from de- scriptions of treatment in trials and reviews? BMJ 336(7659):1472-1474 DOI 10.1136/bmj.39590.732037.47.
18. Government of Canada. 2015. Tri-Agency statement of principles on digital data man- agement. Available at http:// www.science.gc.ca/ default.asp?lang=En&n=83F7624E-1.
19. Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Tibshirani R. 2014. Increasing value and reducing waste in research design, conduct, and analysis. The Lancet 383(9912):166-175 DOI 10.1016/S0140-6736(13)62227-8.
20. Kilkenny C, Parsons N, Kadyszewski E, Festing MFW, Cuthill IC, Fry D, Altman DG. 2009. Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLOS ONE 4(11):e7824 DOI 10.1371/journal.pone.0007824.
21. Moher D, Altman DG. 2015. Four proposals to help improve the medical research literature. PLOS Medicine 12(9):e1001864 DOI 10.1371/journal.pmed.1001864.
22. Open Science Collaboration. 2015. Estimating the reproducibility of psychological science. Science 349:aac4716 DOI 10.1126/science.aac4716.
23. Open Science Framework. 2016. Open Science Framework: a scholarly commons to connect the entire research cycle. Available at https:// osf.io/ (accessed on 2016 June 14).
24. Percie du Sert N. 2011. Improving the reporting of animal research: when will we ARRIVE? Disease Models & Mechanisms 4(3):281-282 DOI 10.1242/dmm.007971.
25. Powell-Smith A, Goldacre B. 2016. The TrialsTracker: automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions. F1000 5:2629 DOI 10.12688/f1000research.10010.1.
26. Saini P, Loke YK, Gamble C, Altman DG, Williamson PR, Kirkham JJ. 2014. Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews. BMJ 349:6501-6501 DOI 10.1136/bmj.g6501.
27. Shamseer L, Hopewell S, Altman DG, Moher D, Schulz KF. 2016. Update on the endorsement of CONSORT by high impact factor journals: a survey of journal ``In- structions to Authors'' in 2014. Trials 17(301):1-8 DOI 10.1186/s13063-016-1408-z.
28. Stevens A, Shamseer L, Weinstein E, Yazdi F, Turner L, Thielman J, Altman DG, Hirst A, Hoey J, Palepu A, Schulz KF, Moher D. 2014. Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review. BMJ 348(june):g3804 DOI 10.1136/bmj.g3804.
29. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. 2012. Does the use of the CONSORT statement impact the completeness of reporting of randomised con- trolled trials published in medical journals? a cochrane review. Systematic Reviews 1:60 DOI 10.1186/2046-4053-1-60.